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AbstrAct
Introduction: the issue of commercialization of transplantation analyses in the article. Attention is paid to the importance of transplantation as a method 
of treatment and saving human lives. 
Aim: the clarify the feasibility of the introduction of donation commercialization as an avenue to solve the shortage of donor organs and means of combating 
with black organ market and finding alternative avenues solving these problems, which are more morally acceptable for society is the aim of this article.
Materials and methods: the experience of foreign countries has been analyses in the research. Additionally, we used data from international organizations, 
conclusions scientists and report of Global Financial Integrity in the research. 
Results: it is impossible to solve most problems by means of paid donation.
Conclusions: therapeutic organ and tissue cloning based on genetic technology is the best way out and solving ethical transplantation problems.
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InTROducTIOn 
Transplantology has saved thousands of lives and is a standard 
treatment for a number of pathologies, and sometimes is the last 
chance for salving human lives. Taking this into consideration, 
transplantology can be called the phenomenon of the twentieth 
century. Therefore, with its methods, the law shall promote the 
progress of transplantology as a promising and effective treatment. 
However, in terms of general system of values prevailing in 
modern society, the law shall comply with ethical requirements. 
This means that improving the standard of living for some 
people should not worsen the standard of living and health 
for others.
Organ donation and transplantation are a complex and 
sensitive procedure raising ethical, moral, and practical problems. 
The fact that a number of people in a transplant waiting list is 
permanently increasing has been complicating the situation [1]. 
Since the introduction of the transplantation method, a number 
of people in a transplant waiting list has never coincided with a 
number of donors [2, р. 456]. As a result, quite a few potential 
recipients waiting for a donor have ended by dying. [3, р. 13] On 
the other hand, achievements of transplantology over shadow 
the facts of using poor people as a source of donor organs for 
wealthy recipients (“tourists”) crossing the borders to search 
for and buy necessary organs [4].
Continuous improvement of medical technologies to overcome 
rejection of organs and human tissues has led to the fact that 
transplantation has become a significant part of the medical 
services offered to the public. After a successful transplantation, 
one’s lifetime significantly extends and its quality improves [5, 
р. 472]. Nowadays, organ transplantation is the most efficient 
way to treat certain diseases at their end-stage, such as renal 
insufficiency, and is the only method of treatment in the event 
of failure of functioning of organs such as the heart, liver and 
lungs [6, р. 521].
Therefore, the society has realized the importance of 
transplantation as a method of treatment and saving human lives 
and turns from undue criticism to thorough philosophical and 
legal analysis, search for optimal solution of problems existing 
in the sphere oftransplatology.
AIM
The clarify the feasibility of the introduction of donation 
commercialization as an avenue to solve the shortage of donor 
organs and means of combating with black organ market and 
finding alternative avenues solving these problems, which are more 
morally acceptable for society is the purpose of this article.
MATERIALS And METHOdS
The experience of foreign countries has been analyses in the 
research. In particular, Iran, Singapore, Canada as countries 
where commercialization is permitted and India, the Philippines 
and China as countries which had an experience of legal sale of 
donor organs, but have abandoned this way because of numerous 
violations of human rights, spread of transplant tourism and 
long-term negative consequences for human health. Also, we 
used data from international organizations, conclusions scientists 
and report of Global Financial Integrity in the research. 
As shown in the materials of the International Summit 
held in 2008 in Istanbul [4], the level of transplant tourism 
and illegal trafficking of human organs and tissues in the third 
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world countries, countries involved in military operations and 
countries where commercialization has been permitted is higher. 
Commercialization results in the fact that the least socially 
protected segments of the population often become victims of 
the black transplantology [4].
WHO claimed that commercialization for organ transplantation 
is likely to take unfair advantage of the poorest and most vulnerable 
groups of people, undermines altruistic donation and leads to 
profiteering and human trafficking [7, p. 572].The research indicates 
that illegal organ sales are on the rise, and a recent report of Global 
Financial Integrity estimates that the illegal organ sales generate 
profits between $600 million and $1.2 billion per year, with a span 
over many countries [7, p. 572]. These countries include Angola, 
Brazil, China, India, Pakistan, Mexico, Haiti and others.
RESuLTS 
Despite the efforts of international organizations and health 
authorities, donor organ demand has always exceeded their 
supply. It is not possible to attract enough donors by means of 
government programs, benefits. As a result, the controversial 
issue of legalizing donor organ sales arises to the society.
In general, there is a system of living donation and post-mortal 
donation. As for living donation, there are restrictions on the subject 
and a number of people. It is binding to have the voluntary consent 
of a donor and the medical report. Because of these limitations 
90% of organ and tissue transplantations are made from dead 
people. Many world countries have disagreement presumption 
on the posthumous donation (fetal materials). Which means that 
– every adult capable person may give a written agreement or 
disagreement to donate anatomical materials in case of his or her 
death. In the absence of such a statement, anatomical materials of 
a deceased adult capable person can be taken with the consent of 
spouses or relatives who lived with him or her before death.
The legal model of agreement presumption provides that 
if a person did not inform about his or her disagreement to 
transplant their organs during his or her lifetime, it is considered 
that after death his or her organs can be used as donor’s materials, 
moreover consent of relatives is not required.
It should be noted that globally there is no single convention 
or imperative act that would optimize the issues of organ and 
tissue transplantation. However, international acts of soft law 
adopted in the framework of intergovernmental organizations 
are fairly widespread and cover these issues. They concern the 
issues of commercialization as well.
The World Health Organization has repeatedly adopted 
resolutions concerning prevention of commercialization in 
organ and tissue transplantation. Declarations of scientific 
transplantologists’ societies, adopted on the basis of conventions 
or other formal events, are important political instruments. For 
example, the Istanbul Declaration on Organ Trafficking and 
Transplant Tourism [4]. This is a detailing document which 
defines the terms of «organ trade”, “transplant tourism”. Similar 
declarations have been adopted as a result of the Amsterdam [8] 
and vancouver [9] Transplantologists’ Forums. These declarations 
have attracted considerable attention among experts.
The basic principles of these acts are to condemn commercial 
relations while receiving donor organs, voluntary donation, 
priority of the donor’s life and health and priority of cadaveric 
organ donation, and so on. All the above mentioned acts have 
non-normative character and, therefore,can not be considered 
a source of law of full value.
Speaking about regional acts having conventional nature that 
regulate relations concerning organ and tissue transplantation, 
above all, those adopted within the Council of Europe should 
be noted. In particular, the Convention for the Protection of 
Human Rights and Dignity of the Human Being with regard 
to the Application of Biology and Medicine of April 04, 1997 
[10], Additional Protocols to the Convention on Human Rights 
and Biomedicine concerning Transplantation of Organs and 
Tissues of Human Origin [11], Declaration on Human Organ 
Transplantation of October 30, 1987 [12]. The main purpose of 
the Convention and Protocols is to protect honor and dignity, 
personal immunity and other rights and freedoms associated 
with transplantology [10, 11]. 
The fact that the Convention’s acts do not apply to reproductive 
and embryonic organs and tissues as well as blood and its 
components seems rather interesting. This means that bone 
marrow tissue sales are also prohibited, although in practice, 
in most countries, including Ukraine, bone marrow tissue sales 
are permitted.
Currently, organ sales are prohibited in most countries. 
Countries of Europe, North and Latin America have some forms 
of legislation aimed to prevent illegal organ sales, both through 
direct prohibition and through legislation restricting how and 
by whom donation can be made. However, leading European 
surgeons and other experts emphasize that such policies will 
not tackle existing transplantation problems.
Thus, A. Friedman believes that human organ trade should 
be legalized because it will assist to tackle a global problem of 
donor organ shortage. The demand for organ transplantation to 
save lives outstrips supply so much that patients are desperate. 
Increasing percentage of successful cases combined with steady 
expansion of indications for transplantation makes an acute 
shortage progressing. International crime syndicates are making 
a profit out of the shortage, seeking high income originating from 
illegal human organ sales [13]. A. Friedman’s call was joined in 
by other experts [13]. H. Nadey claims that it is impossible to 
ignore the black organ market, and the risk of unregulated organ 
sales outweigh the danger of its legalization. If this trade is still 
on, why do not we make it controllable? It that case, if someone 
wants to give a kidney for a price, it would be acceptable. If it is 
safe to do this, a donor will not be affected [14, p. 15-16]. This 
view was supported by Professor R. Mendoza [15].
Y. Dangatabelieves that commercialization is the only way to 
tackle the problem of donor organ shortage. Given a significant 
gap between a number of donors and a number of people in organ 
waiting lists in countries where organ donation still remains a 
display of altruism, it is high time to amend legislation to adjust 
it to requirements of the present time. The choice is between 
rigidity in maintaining altruism which leads to an increased 
death rate, on the one hand, and flexibility of a multisystem 
organ donation strategy that would revolutionize availability 
of organs to redeem more lives [16, p. 26]. 
C. Erin and J. Harris advocate commercialization and believe 
that all the problems can be tackled in a way that the national 
health system will be the only buyer of organs [17, p. 217]. J. Harris 
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considers persons who become donors after death as “former people” 
who are alive can neither harm nor do good [18, p. 123].
Some experts advocate the idea that each individual owns oneself, 
as well as own property, so only he/she can decide what will happen 
to his/her body, dead or alive [19, p. 631]. Therefore, a potential 
organ donor can decide how to dispose of his/her body. The issue 
of donation serviceability is inextricably linked with the issue of 
the legal status of human organs and tissues. Serviceability will 
mean that the human body is just equal to the things that will have 
a certain price. This will lead to social inequality when some (rich 
people) will live or improve life at the expense of others (socially 
unprotected people). Discussions on the establishment of paid 
donation can be linked with constantly augmentative differences 
between rich and poor, which is a natural trend nowadays.
That immunity and autonomy of the individual have given 
altruistic nature rather than made it a duty to the organ donation 
in most civilized countries [16, p. 23].
Paid donation raises a number of questions. What is the 
legal status of the human body? What is its price? Who has the 
right to dispose of it especially if it concerns the body of the 
deceased? What if the donor will require an organ transplant? 
From the moral point of view, will it lead to the commercialization 
when a seller is “supporting himself/herself with his/her body”, 
because such is, for example, the prostitution situation? What 
might be the likely consequences for the seller’s health in the 
short, medium and long term? [16, p. 26]
Let us refer to the experience of the world. In world practice, 
Iran, Singapore and Australia are the only countries which have 
legally allowed organ and tissue buying and selling. For example, 
the Iranian organ market is internal, that is, foreigners are not 
allowed to buy the Iranian citizens ‘organs. Additionally, organs 
can only be transplanted between people of the same nationality 
- so, for example, an Iranian national cannot purchase a kidney 
from a refugee from another country [20, p. 503]. That is why 
proponents of legalized organ sales mark the Iranian model as 
an effective and safe example of organ sales. It is noted that the 
Iranian model help avoid quite a few problems associated with 
organ sales. [21, p. 1136].
Some critics argue that the Iranian system is coercive in some 
ways, as over 70% of donors are considered poor by Iranian 
standards [22, p. 7] and the donation is the last chance of survival. 
In fact, there is evidence that Iranian donors experience highly 
negative outcomes, both in terms of health and emotional well-
being [23, p. 10]. 
Before 2008, the organ sale was legal in the Philippines, and 
the country was a popular destination for transplant tourism. 
The Philippine Information Agency, a governmental agency, 
even promoted “all-inclusive” kidney transplant packages that 
retailed for roughly $25,000 [24, p. 193]. The government banned 
the organ sale in March, 2008.
Before the Transplantation of Human Organs Act (THOA) 
was passed in 1994, India had a successful legal organ sales 
market. Low costs and high availability turned India into one 
of the largest kidney transplant centers in the world.
However, several problems began to surface. In some cases, 
patients even were unaware that kidney transplantation was 
done. In other cases, patients were promised payments that 
were much higher than what they actually received. These and 
other ethical issues pushed the Indian government into passing 
a legislation prohibiting organ sales [25]. Nevertheless, current 
laws still contain some loopholes. For example, the THOA states 
that an organ donor shall be a relative, spouse, or an individual 
donating for reasons of “affection” for the recipient. Often, 
claims of “affection” are unfounded and the organ donor has 
no connection to the recipient. [26, p. 21].
In China, in 1984, forced extraction of executed prisoners’ 
organs was established by law, but under pressure from the 
European community, the government pledged to cease such 
operations by 2015. However, in fact, this was not done. In 2007, 
its borders were sealed for «transplant tourism” foreigners. By 
the time, China had been one of the largest service providers 
in the field of transplantation for foreigners.
So, the legalization of organ and tissue sales has not resulted 
in the desired effect, it only generates some additional ethical 
issues. The black transplantology is a phenomenon that has 
been a matter regardless of whether the organ sale has been 
authorized or not. 
Ukraine is in difficult social and economic conditions now, 
there is a constant increase in the number of socially disadvantaged 
groups (due refugees). That It is therefore necessary to adhere 
to the prohibition of any trade schemes and control of the state. 
The government should take the compensation liability to the 
donor, not the recipient [27, p. 38].
dIScuSSIOn
So, instead of fighting the black transplantology and transplant 
tourism, the governments strive to raise the level of GDP through 
the commercialization of organ donation and automatically 
recognize legitimate illegal profits by listing them in the budget. 
Such a policy is unacceptable.
The idea of cell, tissue and organ serviceability threatens taking 
unfair advantage of the poorest and most vulnerable groups of 
people, thus undermining the idea of gratuitous donation, which 
ultimately leads to profiteering and human trafficking. Such 
payments seem to point out that some people are deprived of 
dignity and are just objects to be used by others. The aim of this 
principle, in addition to preventing human material trafficking, 
is to mark the special merit, which is the gratuitous provision 
of human materials to save and prolong human life.
To combat the illegal organ sales, M. Moniruzzman recommends: 
1) global governance; 2) transparency and accountability; 3) 
preference of cadaveric organ donation [28]. So, as we can see, 
the paid donation is out of question.
In addition, experts suggest several ways to solve the problem. 
For example, creation of artificial organs on the basis of «artificial 
kidney” apparatus, transplantation of animal organs from to 
humans (xenotransplantation), cloning organs [29]. 
By the way, nowadays there have been some attempts to 
clone whole organs, particularly, the liver. This method is 
called therapeutic cloning. Therapeutic cloning is the same 
as reproductive cloning, but limited to 14 day term of the 
embryo’s growth. For the first 14 days, embryonic cells are 
formed that can continue to turn into specific tissue cells of 
individual organs –the heart, kidneys, liver, pancreas and 
others, and be used for treatment of many diseases in medicine. 
In many countries, scientists are allowed to use therapeutic 
Principle of serviceability and gratuitousness in transplantation?
568
cloning and conduct experiments on stem cells for medical 
purposes [29].
That is true, no one resents buying and selling hair. Even 
less public resentment is caused by an opportunity of intake 
of blood, sperm, skin parts, placenta and others. The problem 
is being aggravated when the subject of discussion is human 
organs: kidneys, lungs, liver, heart, etc. However, the principle of 
non-commercialization should be a guarantee of human rights, 
freedoms and interests, reasonable balance between the rights 
of a donor and recipient until the moment when artificial organ 
and tissue growing or therapeutic cloning become common.
cOncLuSIOnS 
In our opinion, therapeutic organ and tissue cloning based 
on genetic technology is the best way out and solving ethical 
transplantation problems. By the time of the proper development 
of specified vector of medicine, the ban on the human organ 
and tissue sales should be in force.
In addition, we should raise a question at UN level of adopting 
a single imperative conventional act that prohibits commercial 
relations in the field of transplantology, optimizes organ and tissue 
transplantation. You should also raise a question of responsibility, 
not only persons who are engaged illegal transplantation, but 
also transplant tourists.
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